Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers

被引:37
|
作者
Li, Ye [1 ]
Miao, Xiaoqing [1 ]
Chen, Tongkai [1 ]
Yi, Xiang [2 ]
Wang, Ruibing [1 ]
Zhao, Haitao [3 ,4 ]
Lee, Simon Ming-Yuen [1 ]
Wang, Xueqing [5 ]
Zheng, Ying [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
[2] Univ North Carolina Chapel Hill, UNC Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC 27516 USA
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China
[4] Peking Union Med Coll, Beijing 100730, Peoples R China
[5] Peking Univ, Sch Pharmaceut Sci, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
Zebrafish; Transport; Biological barriers; Nanocrystals; BLOOD-BRAIN-BARRIER; IN-VIVO; INTESTINAL-ABSORPTION; ORAL BIOAVAILABILITY; CELLULAR UPTAKE; PARTICLE-SIZE; NANOPARTICLES; NANOCRYSTALS; VITRO; BIODISTRIBUTION;
D O I
10.1016/j.colsurfb.2017.05.022
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
With the wide application of nanotechnology to drug delivery systems, a simple, dynamic and visual in vivo model for high-throughput screening of novel formulations with fluorescence markers across biological barriers is desperately needed. In vitro cell culture models have been widely used, although they are far from a complimentary in vivo system. Mammalian animal models are common predictive models to study transport, but they are costly and time consuming. Zebrafish (Danio rerio), a small vertebrate model, have the potential to be developed as an "intermediate" model for quick evaluations. Based on our previously established coumarin 6 nanocrystals (C6-NCs), which have two different sizes, the present study investigates the transportation of C6-NCs across four biological barriers, including the chorion, blood brain barrier (BBB), blood retinal barrier (BRB) and gastrointestinal (GI) barrier, using zebrafish embryos and larvae as in vivo models. The biodistribution and elimination of C6 from different organs were quantified in adult zebrafish. The results showed that compared to 200 nm C6-NCs, 70 nm C6-NCs showed better permeability across these biological barriers. A FRET study suggested that intact C6-NCs together with the free dissolved form of C6 were absorbed into the larval zebrafish. More C6 was accumulated in different organs after incubation with small sized NCs via lipid raft-mediated endocytosis in adult zebrafish, which is consistent with the findings from in vitro cell monolayers and the zebrafish larvae model. C6-NCs could be gradually eliminated in each organ over time. This study demonstrated the successful application of zebrafish as a simple and dynamic model to simultaneously assess the transport of nanosized drug delivery systems across several biological barriers and biodistribution in different organs, especially in the brain, which could be used for central nervous system (CNS) drug and delivery system screening. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [1] Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers
    Cojocaru, Florina-Daniela
    Botezat, Doru
    Gardikiotis, Ioannis
    Uritu, Cristina-Mariana
    Dodi, Gianina
    Trandafir, Laura
    Rezus, Ciprian
    Rezus, Elena
    Tamba, Bogdan-Ionel
    Mihai, Cosmin-Teodor
    PHARMACEUTICS, 2020, 12 (02)
  • [2] Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
    Ghaffarian, Rasa
    Muro, Silvia
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (80):
  • [3] Peptides as drug delivery vehicles across biological barriers
    Ghosh D.
    Peng X.
    Leal J.
    Mohanty R.P.
    Journal of Pharmaceutical Investigation, 2018, 48 (1) : 89 - 111
  • [4] Carbohydrate Based Nanoparticles for Drug Delivery Across Biological Barriers
    Peptu, Catalina Anisoara
    Ochiuz, Lacramioara
    Alupei, Liana
    Peptu, Cristian
    Popa, Marcel
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (09) : 2107 - 2148
  • [5] Cyclodextrins in Drug Delivery Systems and Their Effects on Biological Barriers
    Haimhoffer, Adam
    Rusznyak, Agnes
    Reti-Nagy, Katalin
    Vasvari, Gabor
    Varadi, Judit
    Vecsernyes, Miklos
    Bacskay, Ildiko
    Feher, Palma
    Ujhelyi, Zoltan
    Fenyvesi, Ferenc
    SCIENTIA PHARMACEUTICA, 2019, 87 (04)
  • [6] The use of TPGS in drug delivery systems to overcome biological barriers
    Luiz, Marcela Tavares
    Di Filippo, Leonardo Delello
    Alves, Renata Carolina
    Sousa Araujo, Victor Hugo
    Duarte, Jonatas Lobato
    Marchetti, Juliana Maldonado
    Chorilli, Marlus
    EUROPEAN POLYMER JOURNAL, 2021, 142
  • [7] Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
    Awasthi, Vibhudutta
    Bulotta, Stefania
    Cosco, Donato
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Recent Advances in Drug Design and Delivery Across Biological Barriers Using Computational Models
    Vanshita
    Gar, Akash
    Dewangan, Hitesh Kumar
    LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (10) : 865 - 876
  • [9] Enhancement of polymer thermoresponsiveness and drug delivery across biological barriers by addition of small molecules
    Zhang, Zipei
    Li, Xiyu
    Do, Changwoo
    Kohane, Daniel S.
    HELIYON, 2023, 9 (06)
  • [10] INTERACTIONS BETWEEN POLYMERIC DRUG DELIVERY SYSTEMS AND BIOLOGICAL-SYSTEMS - BARRIERS AND OPPORTUNITIES
    HIMMELSTEIN, KJ
    ACS SYMPOSIUM SERIES, 1991, 469 : 34 - 41